Shumin (Sam) Liu
Company: Shenzhen Enduring Biotech
Job title: CEO
Seminars:
PEG-Based Bispecific ADC: Better Tumor Penetration, Wider Therapeutic Window 4:00 pm
Assessing how it provides better tumor penetration Discussing how there were not any Fc related toxicities Exploring how it has a wider therapeutic windowRead more
day: Day Two